SEC Form 4 · accession 0001144204-18-012533

DarioHealth Corp. · DRIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Feb 28, 2018

Accepted (ET)

Mar 2, 2018 · 4:07 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001533998

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Feb 28, 2018	P	9,018	$1.40	A	9,018	I	By spouse
Common Stock	holding	—	—		—	435,766	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series C Convertible Preferred Stock^F1,F2	$1.40	Feb 28, 2018	P	13,349	A	—	—	Common Stock	26,698	13,349	I
Warrant to purchase Common Stock^F1,F3	$1.80	Feb 28, 2018	P	28,573	A	Aug 28, 2018	Aug 28, 2019	Common Stock	28,573	28,573	I

F1The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2The Series C Convertible Preferred Stock automatically converts into Common Stock on a 1:2 basis upon shareholder approval of the conversion and has no expiration date.
F3The Warrants were issued in connection with the purchase of the Common Stock and the Series C Convertible Preferred Stock reported herein.